PubRank

Hyun Chang

Author PubWeight™ 19.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012. Helicobacter 2012 1.40
2 Primary tracheal tumors: review of 37 cases. J Thorac Oncol 2009 1.21
3 Outcomes of multiple salvage chemotherapy for advanced gastric cancer: implications for clinical practice and trial design. Cancer Chemother Pharmacol 2010 0.96
4 The early discontinuation of palliative chemotherapy in older patients with cancer. Support Care Cancer 2013 0.91
5 Endoscopic management of recurrent tracheoesophageal fistula with trichloroacetic acid chemocauterization: a preliminary report. J Pediatr Surg 2008 0.88
6 Protective effects of garlic extract, PMK-S005, against nonsteroidal anti-inflammatory drugs-induced acute gastric damage in rats. Dig Dis Sci 2014 0.86
7 Who should be admitted to the intensive care unit? The outcome of intensive care unit admission in stage IIIB-IV lung cancer patients. Med Oncol 2014 0.85
8 Association of polymorphisms in virulence factor of Helicobacter pylori and gastroduodenal diseases in South Korea. J Gastroenterol Hepatol 2014 0.85
9 Preoperative thrombocytosis is a significant unfavorable prognostic factor for patients with resectable non-small cell lung cancer. World J Surg Oncol 2014 0.83
10 Sorafenib-induced tumor response in a patient with metastatic epithelioid angiomyolipoma. J Clin Oncol 2014 0.82
11 The Effect of Cochinchina momordica Seed Extract on Gastric Acid Secretion and Morphologic Change in Aged Rat Stomach. Gut Liver 2013 0.80
12 The burden of nosocomial staphylococcus aureus bloodstream infection in South Korea: a prospective hospital-based nationwide study. BMC Infect Dis 2014 0.80
13 A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC). Lung Cancer 2012 0.80
14 Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators. J Cancer Res Clin Oncol 2009 0.80
15 Novel experimental rabbit model of anterior glottic web formation. Acta Otolaryngol 2015 0.79
16 Long-term survival after surgical resection for liver metastasis from gastric cancer: two case reports. Cancer Res Treat 2006 0.79
17 Continuity of the incudostapedial joint: a novel prognostic factor in postoperative hearing outcomes in congenital aural atresia. Acta Otolaryngol 2011 0.78
18 Sclerosing encapsulating peritonitis (abdominal cocoon) after abdominal hysterectomy. Korean J Intern Med 2007 0.78
19 Predictable Marker for Regression of Barrett's Esophagus by Proton Pump Inhibitor Treatment in Korea. J Neurogastroenterol Motil 2013 0.77
20 Fat deposition in the tunica muscularis and decrease of interstitial cells of Cajal and nNOS-positive neuronal cells in the aged rat colon. Am J Physiol Gastrointest Liver Physiol 2014 0.77
21 Comparison of Indomethacin, Diclofenac and Aspirin-Induced Gastric Damage according to Age in Rats. Gut Liver 2012 0.77
22 Influence of TGFB1 C-509T polymorphism on gastric cancer risk associated with TGF-β1 expression in the gastric mucosa. Gastric Cancer 2014 0.77
23 The Effect of Helicobacter pylori on Epidermal Growth Factor Receptor-Induced Signal Transduction and the Preventive Effect of Celecoxib in Gastric Cancer Cells. Gut Liver 2013 0.76
24 Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided versus empirical chemotherapy in unresectable non-small cell lung cancer. Anticancer Res 2009 0.76
25 Salvage treatment with low-dose weekly paclitaxel in elderly or poor performance status patients with metastatic urothelial carcinoma. Tumori 2014 0.75
26 Pediatric tracheostomy revisited: a nine-year experience using horizontal intercartilaginous incision. Laryngoscope 2014 0.75
27 Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer: activity independence of prior docetaxel resistance. Cancer Chemother Pharmacol 2009 0.75
28 Paclitaxel as third-line chemotherapy for small cell lung cancer failing both etoposide- and camptothecin-based chemotherapy. Medicine (Baltimore) 2017 0.75